From December 18, 2023 to December 31, 2023, the company has repurchased 647,000 shares, representing 0.14% for CNY 39.99 million. With this, the company has completed the repurchase of 647,000 shares, representing 0.14% for CNY 39.99 million under the buyback announced on December 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.45 CNY | -3.41% | -9.50% | -49.74% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.74% | 2.09B | |
-22.94% | 7.77B | |
+76.66% | 4.51B | |
+6.87% | 2.76B | |
-2.63% | 2.67B | |
-18.39% | 1.72B | |
-19.40% | 1.49B | |
+20.88% | 1.22B | |
-45.82% | 1.12B | |
+20.68% | 1.05B |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.